Safety first: Robert Lanza, chief scientific officer of Advanced Cell Technology, says the two patients in an early stage of a stem-cell study have shown no negative side effects from the treatment.
See original here:
Eye Study Is a Small but Crucial Advance for Stem-Cell Therapy
Colorado man waiting to hear whether experimental treatment will help reverse the effects of his Type 1 diabetes . Salt Lake City (PRWEB) January 26, 2012 Researchers at Utah-based Optimum Clinical Research have completed a study to determine whether stem cells could reverse the effects of Type 1 diabetes.
Advanced Cell Technology, Inc. , a leader in the field of regenerative medicine, announced today the dosing of an additional patient in its Phase 1/2 trial for Stargardt’s macular dystrophy using retinal pigment epithelial cells derived from human embryonic stem cells .
See the rest here:
ACT Announces that Additional Patient with Stargardt’s Disease Has Undergone Embryonic Stem Cell Transplantation at …
Stem cell research, while controversial, has always been touted as the future of disease treatment. There's more evidence to support that claim, as it turns out that stem cell treatment can help cure blindness.
Originally posted here:
Stem Cell Treatment For Blindness Works, and Is Safe [Medicine]
First results from test of embryonic stem cell therapy has shown improved vision in two patients, but researchers caution results are not a cure for the blind.
See original here:
Stem cell treatment improves eyesight
A treatment that improved the vision of two women with forms of macular degeneration could be a breakthrough for regenerative medicine after a recent setback.
Read more:
Embryonic Stem Cell Study Shows Promise
COLUMBIA, S.C. (AP) – An expert in the area of stem cell research in medicine is speaking at the University of South Carolina.
Continued here:
USC hosts speaker on stem cell studies in medicine
Advanced Cell Technology, Inc. , a leader in the field of regenerative medicine, today announced treatment of the first patient in its Phase 1/2 clinical trial for Stargardt’s macular dystrophy using retinal pigment epithelial cells derived from human embryonic stem cells .
Original post:
ACT Announces Europe’s First Human Embryonic Stem Cell Transplant in Patient with Stargardt’s Disease
MARLBOROUGH, Mass.–(BUSINESS WIRE)– Advanced Cell Technology, Inc.
View post:
ACT Publishes First Report of Embryonic Stem Cell (ESC)-Derived Cells Transplanted Into Patients
Therapy with embryonic stem cells has managed to improve the sight of two people with extremely limited vision, in the first clinical trial of the controversial technique in humans.
Visit link:
Human stem cell therapy works in blind patients in first trial